Laserfiche WebLink
8. This endorsement does not create a duty on ourpart to defend the additional insuredor to par- <br />ticipate in, contribute to, or reimburse any person, organization or entity for any fees or expenses <br />incurred in the defense of the additional insured. <br />SECTION IV —COMMERCIAL GENERAL LIABILITY CONDITIONS, Condition B. INSURED'S DUTIES <br />IN THE EVENT OF OCCURRENCE, OFFENSE, CLAIM OR SUITof the policy is amended to include: <br />An additional insuredunder this endorsement shall in addition to complying with all provisions of the <br />policy: <br />1. Give written notice tous of an occurrence or an offense which may result in a claim or suit with- <br />in thirty (30) days of notice to the additional insured. <br />2. Give written notice to us of a claim or suit brought against the additional insured within thirty <br />(30) days of the additional insured being served with the claim or suit. <br />3. Give written notice to any other insurer who has or may have coverage under its policy or policies <br />for a claim,suit or demand for defense or indemnity within thirty (30) days of the additional in- <br />sured being served with the claim,suitor demand for defense or indemnity.Such notice must <br />demand the full coverage available under the policy.The additional insured will not take any ac- <br />tion to waive or limit such other coverage available to it. <br />4. Obtain and provide to us copies of each and every policy from each and every insurer identified <br />pursuant to the preceding paragraph. <br />The coverage provided by this endorsement is primary and non-contributory and no insurance held or <br />owned by the additional insured shall be called upon to cover damages under this policy up to the limits <br />of this policy, but only if the bodily injury or property damage under this policy is caused directly, in <br />whole or in part, from your ongoing operations performed for the additional insured. <br />This endorsement is subject to all terms, conditions and exclusions of the policy, which remain <br />unchanged. <br />10/28/2025 <br />AUTHORIZED REPRESENTATIVE DATE <br />SDS-8 (1-18) Page 2 of 2 <br />